The Cooper Companies, Inc. (NASDAQ:COO) Position Raised by Steward Partners Investment Advisory LLC

Steward Partners Investment Advisory LLC increased its position in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 19.1% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,407 shares of the medical device company’s stock after purchasing an additional 226 shares during the period. Steward Partners Investment Advisory LLC’s holdings in Cooper Companies were worth $129,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. State Street Corp raised its position in shares of Cooper Companies by 1.2% during the third quarter. State Street Corp now owns 8,590,689 shares of the medical device company’s stock worth $947,897,000 after purchasing an additional 104,521 shares during the period. JPMorgan Chase & Co. raised its holdings in shares of Cooper Companies by 13.2% during the third quarter. JPMorgan Chase & Co. now owns 4,930,022 shares of the medical device company’s stock valued at $543,979,000 after acquiring an additional 573,908 shares during the period. Geode Capital Management LLC raised its holdings in shares of Cooper Companies by 1.0% during the third quarter. Geode Capital Management LLC now owns 4,796,556 shares of the medical device company’s stock valued at $527,476,000 after acquiring an additional 48,559 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its holdings in shares of Cooper Companies by 11.9% during the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 1,818,610 shares of the medical device company’s stock valued at $200,665,000 after acquiring an additional 194,118 shares during the period. Finally, Champlain Investment Partners LLC raised its stake in Cooper Companies by 8.0% during the 3rd quarter. Champlain Investment Partners LLC now owns 1,818,345 shares of the medical device company’s stock valued at $200,636,000 after purchasing an additional 134,875 shares during the period. Institutional investors own 24.39% of the company’s stock.

Cooper Companies Stock Performance

Shares of COO opened at $81.22 on Monday. The company’s fifty day moving average is $91.20 and its 200-day moving average is $98.93. The Cooper Companies, Inc. has a 12 month low of $77.05 and a 12 month high of $112.38. The firm has a market cap of $16.24 billion, a price-to-earnings ratio of 41.65, a price-to-earnings-growth ratio of 2.25 and a beta of 1.02. The company has a quick ratio of 1.12, a current ratio of 1.91 and a debt-to-equity ratio of 0.32.

Cooper Companies (NASDAQ:COO) last posted its earnings results on Thursday, March 6th. The medical device company reported $0.92 EPS for the quarter, hitting the consensus estimate of $0.92. Cooper Companies had a net margin of 10.07% and a return on equity of 9.38%. The firm had revenue of $964.70 million for the quarter, compared to the consensus estimate of $981.25 million. Equities analysts expect that The Cooper Companies, Inc. will post 3.98 EPS for the current fiscal year.

Wall Street Analyst Weigh In

COO has been the topic of several recent analyst reports. JPMorgan Chase & Co. cut their target price on shares of Cooper Companies from $120.00 to $110.00 and set an “overweight” rating on the stock in a research note on Friday, March 7th. Needham & Company LLC reissued a “hold” rating on shares of Cooper Companies in a research report on Friday, March 7th. Morgan Stanley dropped their target price on Cooper Companies from $104.00 to $102.00 and set an “equal weight” rating on the stock in a report on Friday, December 6th. StockNews.com lowered shares of Cooper Companies from a “buy” rating to a “hold” rating in a research note on Wednesday, December 11th. Finally, Piper Sandler reiterated an “overweight” rating and issued a $115.00 price objective (down previously from $120.00) on shares of Cooper Companies in a research note on Friday, March 7th. Three research analysts have rated the stock with a hold rating and eight have issued a buy rating to the stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $111.89.

Cooper Companies Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.